2017 年 52 巻 2-3 号 p. 134-147
As of December 31, 2016, a total of 8,825 liver transplants have been performed in 67 institutions in Japan. There were 378 deceased donor transplants (375 from heart-beating donor and 3 from non-heart-beating donor) and 8,447 living-donor transplants. The annual total of liver transplants in 2016 was 438 (57 deceased donor transplants and 381 living-donor transplants). The most frequent indication was cholestatic disease, followed by neoplastic disease. As for the graft liver in living-donor cases, right lobe graft was the most popular (35%). Patient survivals following transplantation from heart-beating donors (1-year 88.1%, 3-year 84.8%, 5-year 82.3%, 10-year 76.7%, and 15-year 76.7%) were similar to those from living-donors (1-year 84.7%, 3-year 80.6%, 5-year 78.2%, 10-year 72.8%, 15-year 68.5%, 20-year 66.0%, and 25-year 65.2%). Graft survivals were very much the same as patient survivals. Survival data were provided according to age and sex of recipients, indication, age and sex of donors, ABO-compatibility, and other factors.
